Chronic, intermittent treatment with a cannabinoid receptor agonist impairs recognition memory and brain network functional connectivity

Elucidating how cannabinoids affect brain function is instrumental for the development of therapeutic tools aiming to mitigate ‘on target’ side effects of cannabinoid‐based therapies. A single treatment with the cannabinoid receptor agonist, WIN 55,212‐2, disrupts recognition memory in mice. Here, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Mouro, Francisco M., Ribeiro, Joaquim A., Sebastião, Ana M., Dawson, Neil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220860/
https://www.ncbi.nlm.nih.gov/pubmed/29989183
http://dx.doi.org/10.1111/jnc.14549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220860/
https://www.ncbi.nlm.nih.gov/pubmed/29989183
http://dx.doi.org/10.1111/jnc.14549

Ejemplares similares